EMEA-000060-PIP02-08-M06

Key facts

Invented name
Ilaris
Active substance
Canakinumab
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0141/2013
PIP number
EMEA-000060-PIP02-08-M06
Pharmaceutical form(s)
  • Powder for solution for injection
  • Powder and solvent for solution for injection
  • Solution for injection in pre-filled syringe
Condition(s) / indication(s)
Treatment of juvenile idiopathic arthritis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Novartis Europharm Limited
United Kindgom
Tel. +41 6132 41111
E-mail: paediatric.enquiries@novartis.com
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000060-PIP02-08-M06
Compliance opinion date
09/10/2015
Compliance outcome
positive

Decision

How useful was this page?

Add your rating